Blog Posts

Staying current on cutting edge research into genetic/familial high-risk assessment – NCCN

NCCN/LinkedIn

Nov 21, 2024, 10:02

Staying current on cutting edge research into genetic/familial high-risk assessment – NCCN

National Comprehensive Cancer Network (NCCN) shared a post on LinkedIn:

“NCCN expands two major resources to help cancer care providers and other stakeholders stay current on cutting edge research into genetic/familial high-risk assessment.”

Read further.

Staying current on cutting edge research into genetic/familial high-risk assessment - NCCN

More posts featuring National Comprehensive Cancer Network.

cancer genetic/familial high-risk National Comprehensive Cancer Network NCCN OncoDaily Oncology

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Aug 21, 2025, 12:34

Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation

Immune Oncology

Aug 21, 2025, 12:34

PPP2R1A Mutations as a Biomarker in Immunotherapy: New Insights from Ovarian Clear Cell Carcinoma

Insight

Aug 21, 2025, 12:31

Alisher Kahharov: Uzbekistan's First National Breast Cancer Guideline - A Collaborative Effort with WHO and Georgian Experts

Radiotherapy

Aug 21, 2025, 12:31

New RT Paper Alert: Novel NOVEMBER Trial Puts 9-Day Breast Cancer Radiation Schedule to the Test

Opinion

Aug 21, 2025, 12:03

UICC Enhances Cancer Care with Nutrition and Psycho-Oncology Support

Voices

Aug 21, 2025, 11:40

FDA has Granted Full Market Approval for Papzimeos - NIH

Insight

Aug 21, 2025, 11:16

Kefah Mokbel: TAD Proven Safe with Effective Long-Term Outcomes for Breast Cancer Patients

Voices

Aug 21, 2025, 11:15

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

OncoDaily Pulse

Aug 21, 2025, 10:23

Archana Ajmera: Meet the Experts of VIRO 2025

OncoDaily Pulse

Aug 21, 2025, 10:08

Yüksel Ürün: Meet the Experts of VIRO 2025

Voices

Aug 21, 2025, 09:46

Pratiti Bandopadhayay: Urgent Need to Sustain Funding for Pediatric Brain Tumor Trials

Voices

Aug 21, 2025, 09:30

Jana Ellegast: Inflammatory Signaling in the Pathogenesis of AML